Search

Your search keyword '"Abbadessa V"' showing total 186 results

Search Constraints

Start Over You searched for: Author "Abbadessa V" Remove constraint Author: "Abbadessa V"
186 results on '"Abbadessa V"'

Search Results

5. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis

6. Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapy. (Case Report)

11. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART

12. Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura – haemolytic uraemic syndrome

13. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab

14. Chronic myeloid leukemia as second malignancy; restrospective multicentric study

15. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

16. Chronic myeloid leukemia as second malignancy; a retrospective multicentrico study

17. Chronic myeloid leukemia as second malignancy: a retrospective multicentric study

18. Bendamustin in association with Rituximab (BR) in the treatment of patients with relapsed/refractory lymphoid neoplasm. A GISL retrospective study

19. Response-based chemotherapy and involved field radiation for intermediate stage Hodgkin disease. A GISL/NHLSG trial

22. Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI

23. Hema e-Chart: Italian Registry for prospective analysis of epidemiology,management and outcome of febrile events in patients with hematologicalmalignancies

25. THE SCREEN PROJECT: A CML DATA REGISTRY IN SICILY AND CALABRIA

29. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

30. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

31. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

32. Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis

33. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

34. A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads

35. Economic evaluation of HIV treatments: The I.CO.N.A. cohort study

40. Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study

42. The Interactions Between Grazing Behaviour, Management And Landscape Objectives – Experiences From Livestock Systems In European Marginal Areas

Catalog

Books, media, physical & digital resources